Iroko Pharmaceuticals LLC

Iroko Pharmaceuticals LLC

Iroko Pharmaceuticals LLC

Overview
Date Founded

2007

Headquarters

One Kew Place,150 Rouse Boulevard,Philadelphia, PA 19112

Type of Company

Private

Employees (Worldwide)

160

Industries

Pharmaceuticals
Biotechnology
Wholesale: Medical Supplies & Pharmaceuticals

Company Description

Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA.

Contact Data
Trying to get in touch with decision makers at Iroko Pharmaceuticals LLC? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Executive Director Global Supply Operations

Chief Financial Officer & Senior Vice President

Senior Vice President & General Counsel

Chief Medical Officer & Vice President, Research & Development

Director Quality Assurance

Project Coordinator

Information Technology Director

Senior Education Coordinator

Senior Vice President-Pharmacovigilance & Medical Information

Board of Directors

Chairman at iCeutica Pharmaceuticals, Inc.

Chief Executive Officer at Iroko Pharmaceuticals LLC

Founder at Kew Capital LLP

Paths to Iroko Pharmaceuticals LLC
Potential Connections via
Relationship Science
You
Iroko Pharmaceuticals LLC
Key Stats and Financials As of 2018
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$45.7M
Non-Profit Donations & Grants
$1,000 - $4,999
2011
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Iroko Pharmaceuticals LLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Iroko Pharmaceuticals LLC's profile does not indicate a business or promotional relationship of any kind between RelSci and Iroko Pharmaceuticals LLC.